Jarden Sticks to Its Buy Rating for Integral Diagnostics Ltd. (IDX)
Jarden Adjusts Integral Diagnostics' Price Target to AU$3.68 From AU$3.72, Keeps at Buy
Integral Diagnostics Price Target Raised 10% to A$3.30/Share by Ord Minnett
Ord Minnett Sticks to Its Buy Rating for Integral Diagnostics Ltd. (IDX)
Wall Street Analysts Are Bullish on Top Healthcare Picks
Ord Minnett Sticks to Their Buy Rating for Integral Diagnostics Ltd. (IDX)
Integral Diagnostics Raised to Overweight From Mkt Weight by Wilsons >IDX.AU
Integral Diagnostics Price Target Raised 11% to A$3.00/Share by Ord Minnett
Morgan Stanley Adjusts Integral Diagnostics' Price Target to AU$1.85 From AU$1.70, Keeps at Underweight
Analysts Offer Insights on Healthcare Companies: Integral Diagnostics Ltd. (AU:IDX), Biophytis SA (Stuttgart: DE:6XB) and Merck KGaA (GB:0O14)
No Data